3-BROMOPYRAZOLO[1,5-A]PYRIMIDIN-5-OL, 95.0%, 250mg

N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide, 98%, 1g

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, 95.0%, 250mg

(2S,4S)-1-(tert-Butoxycarbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 95.0%, 100mg

O,O-Di(pyridin-2-yl) carbonothioate, 98.0%, 25g

Methyl 4-amino-2-chloro-5-methoxybenzoate, 95.0%, 5g

2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-cyclopropylacetamide, 95.0%, 5g

tert-butyl N-[(1R)-3-(bromomethyl)cyclopentyl]carbamate, 97%, 100mg

(3,3-DIMETHOXY-CYCLOBUTYL)METHYLBROMIDE, 95.0%, 250mg

N-2-Cyclohexylethyl-N-methylamine, 98%, 500mg

1-Phenyltridecan-1-one, 98%, 2g

(R)-N-Methyl-1,1,1-trifluoro-2-propylamine, 98.0%, 1g

Plan strain-free PLPOLi 100x/1.25 oil immersion IOS objective for iScope transmitted polarization, 0.17 mm cover glass correction. Working distance 0.13 mm